Skip to main content

PP Compound Market for Automotive Industry expected to grow at CAGR of 5.6%


 

The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts.


Growth of PP Compound Market for the Automotive  Industry

Polypropylene compounds are a kind of resin made from a mixture of one or more base polyolefins. This compound is the base resin that is then mixed with different pigments and additives, which alter the characteristics of the products accordingly depending on the intended use. These polypropylene compounds offer varied applications such as electrical appliances, automotive, building and construction, and furniture components.

 

Benefits of PP Compound

Polypropylene can provide some great benefits to manufacturers who use auxiliary parts of cars . For instance, if the car's bumper is made out of polypropylene, it will be more efficient and reduce fuel consumption on long drives. Alternatively, PP bumpers are more resilient than regular ones and won't break as easily!

They also help vehicles achieve greater fuel efficiency without compromising their cockpit design. Polypropylene is also used to make inexpensive components so manufacturers can keep costs low while generating high levels of profit over time. Some examples of PP compound containing components are bumpers, seat covers, interior panels, lighting instruments, and doors handles.  

 

Impact of COVID-19 

Due to the pandemic brought on by COVID-19, the PP compound industry saw a substantial decrease in production due to many countries imposing indefinite quarantine orders. Automobile production in 2020 saw a decline of nearly 16% due to the impact of COVID-19. As automobile production declined, the demand for PP compounds also saw a sharp dip since these compounds are an essential component of most automobiles.


PP Compound Market for Automotive Industry

According to the market intelligence published by BIS Research, the global PP compound market for the automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031.

Products covered under the PP compound for the automotive industry include thermoplastic polyolefins (TPO) and thermoplastic vulcanizate (TPV), mineral-filled, glass-reinforced, and additive concentrate. The market for thermoplastic polyolefin (TPO) and thermoplastic vulcanizates (TPV) is flourishing. Both TPO’s and TPV’s, among many other products in the compounding business, have a wide variety of applications in the automotive industry. They can be used to manufacture several different parts used in cars, such as body panels, bumpers, wheels, and covers, among many other components.

The compound market for PP is expected to grow primarily because of the need to reduce vehicles’ weight and demand for cheaper products that can be used in automotive parts.

Asia-Pacific (APAC) is the largest consumer of PP compounds, majorly because of China, India, Japan, and South Korea being some of the largest vehicle manufacturers globally. They produce more than 50% of all vehicles produced around the globe every year.

 

Factors Influencing Growth of PP Compound Industry

The major influencing factors for the growth of the PP compound market include regulatory push to increase the adoption of lightweight materials, increasing demand for long fiber polypropylene compound, increasing demand for pp compounds in automotive interiors, and demand for materials that require negligible paint processing.

 

Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Lung Cancer Genomic Testing Market Industry Structure, Development, Demographics, Demands, Main Players, Innovative Technologies, and Opportunities Till 2031

  The shift of healthcare systems toward precision diagnostic and precision medicine will drive the adoption of lung cancer genomic testing facilitating informed treatment decision making and improving healthcare outcomes. Increasing recommendations by the international oncology societies for the use of genomic testing for lung cancer diagnosis provides major opportunities in the global lung cancer genomic testing market. The  lung cancer genomic testing medicine market  was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031. The growth in the global lung cancer genomic testing market is expected to be driven by increasing awareness and adoption of the lung cancer genomic testing market, recent launches of novel lung cancer genomic testing, and the expanding research in the field of lung cancer with an emphasis on pharmacogenomics and development of companion diagnostics. Im...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...